Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- KINGS COLLEGE LONDON
- University of Oxford;
- AALTO UNIVERSITY
- UNIVERSITY OF VIENNA
- DURHAM UNIVERSITY
- King's College London
- Durham University
- Nature Careers
- The University of Edinburgh;
- University of Cambridge;
- University of London
- University of Liverpool
- ;
- Aston University
- City University London
- Heriot Watt University
- Imperial College London
- John Innes Centre
- King's College London;
- Lancaster University
- The University of Manchester;
- University of Cambridge
- University of Greenwich
- University of Greenwich;
- University of Liverpool;
- University of Newcastle
- University of York;
- jobs.ac.uk
- 19 more »
- « less
-
Field
-
international initiatives. To be considered, you must hold, or be close to completion of, a relevant PhD/DPhil in one of the following subjects: computational genomics, genetic or molecular epidemiology, medical
-
background in mathematics, statistics, population genetics, phylogenetics, epidemiological modelling, or machine learning. Highly motivated candidates with some, but not all, of the skills requested will be
-
about our work please go to: Retinal Stem Cell Research - Institute of Genetic Medicine at Newcastle University Annual stipend will be commensurate with experience and training. For informal enquiries
-
, including in medicine, biotech, and fundamental research. SpyTag is a genetically encoded peptide created by the Howarth lab, which forms an irreversible covalent bond to its protein partner SpyCatcher
-
candidate will lead computational lab analysis work across multiple projects, largely focussing on the perturbation of skeletal muscle cells (myofibres) during periods of environmental and/or genetic
-
work closely with lab members but with a focus on EV-associated fungal proteins. They will assist in protocol and technique development and use reverse genetics for functional analysis of EV candidates
-
). The successful applicant will hold a PhD qualification and have experience in microbiology, genetic engineering and bioprocessing. Applications are also welcome from candidates currently pursuing or nearing
-
. The main objectives of Dr Kapetanovic’s research programmes are the: • Development of novel genetic and optogenetic therapies for retinal diseases. • Investigation of innovative ocular surgical techniques
-
motility apparatus through single molecule fluorescence imaging approaches. Underpinning genetic and biochemical experiments will also be required. The project will build on our recent work in this area
-
world-leading researchers from Oxford, Harvard, and other premier institutions to develop innovative gene-silencing and gene-editing technologies targeting the underlying causes of genetic heart diseases